Atherosclerosis
Volume 184, Issue 1 , Pages 1-7, January 2006

Structural modifications of HDL and functional consequences

  • Gianna Ferretti

      Affiliations

    • Institute of Biochemistry, Faculty of Medicine, University of Ancona, via Ranieri 1-60131, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 071 220 4968; fax: +39 071 220 4398.
  • ,
  • Tiziana Bacchetti

      Affiliations

    • Institute of Biochemistry, Faculty of Medicine, University of Ancona, via Ranieri 1-60131, Italy
  • ,
  • Anne Nègre-Salvayre

      Affiliations

    • Inserm UMR-466 and Biochemistry Department, IFR-31, CHU Rangueil, Toulouse, France
  • ,
  • Robert Salvayre

      Affiliations

    • Inserm UMR-466 and Biochemistry Department, IFR-31, CHU Rangueil, Toulouse, France
  • ,
  • Nicole Dousset

      Affiliations

    • FR 1744, University Paul Sabatier, Toulouse, France
  • ,
  • Giovanna Curatola

      Affiliations

    • Institute of Biochemistry, Faculty of Medicine, University of Ancona, via Ranieri 1-60131, Italy

Received 21 April 2005; received in revised form 18 July 2005; accepted 1 August 2005. published online 12 September 2005.

Abstract 

High density lipoproteins (HDL) are susceptible to structural modifications mediated by various mechanisms including oxidation, glycation, homocysteinylation or enzymatic degradation. Structural alterations of HDL may affect their functional and atheroprotective properties. Oxidants, such as hypochlorous acid, peroxyl radicals, metal ions, peroxynitrite, lipoxygenases and smoke extracts, can alter both surface and core components of HDL. The formation of lipid peroxidation derivatives, such as thiobarbituric acid reactive substances, conjugated dienes, lipid hydroperoxides and aldehydes, is associated with changes of physical properties (fluidity, molecular order) and of apoprotein conformation. Non-enzymatic glycation, generally associated with lipoxidation, leads to form irreversible complexes called advanced glycation end products. These HDL modifications are accompanied with altered biological activities of HDL and associated enzymes, including paraoxonase, CETP and LCAT. Homocysteine-induced modification of HDL is mediated by homocysteine-thiolactone, and can be prevented by a calcium-dependent thiolactonase/paraoxonase. Tyrosylation of HDL induces the formation of dimers and trimers of apo AI, and alters cholesterol efflux. Phospholipases and proteolytic enzymes can also modify HDL lipid and apoprotein structure. HDL modification induces generally the loss of their anti-inflammatory and cytoprotective properties. This could play a role in the pathogenesis of atherosclerosis and neurodegenerative diseases such as Alzheimer's disease.

Keywords: Atherosclerosis, High density lipoprotein, Oxidation, Modification, Glycation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(05)00519-8

doi:10.1016/j.atherosclerosis.2005.08.008

Atherosclerosis
Volume 184, Issue 1 , Pages 1-7, January 2006